Cognito's $105 million Series C will advance their pivotal FDA study, expand clinical neurology partnerships, and expand work past Alzheimer's into Parkinsons and beyond.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Swan NeuroTech, a company ...

This photo shows a semi-invasive brain-machine interface at a news conference by the Chinese Institute for Brain Research and NeuCyber NeuroTech Co., Ltd. in Beijing, China, on March 20, 2025. A ...

A number of pivotal announcements this year – including Neuralink’s first brain implant trial, and major funding rounds from companies such as Motif Neurotech with its miniaturized neurostimulator for ...

Technological advancements in various fields of science are shattering what some scientists once deemed impossible. In recent years, researchers have mitigated the existential threat of asteroids, ...

Dr Lew Lim is a scientist and founder of Vielight Inc, a company focused on integrating neuroscience with artificial intelligence. PBM, popularly recognized as "red light therapy," uses red to ...

If the prospect of controlling computers and robots with brainpower alone excites you, neurotech stocks are right up your alley. Unfortunately, today’s top neurotech company — Elon Musk’s Neuralink — ...

Tether’s brand new division, Tether Evo, has completed a $200 million strategic investment in the neural implant firm. Tether — the operator of the eponymous Tether (USDT) stablecoin, the world’s ...

The wearables category already contains multitudes, from exercise-focused smart watches and sleep-tracking smart rings to smart women’s health tech and semi-invasive blood glucose monitors — to name a ...